Citadel Advisors’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.3K Buy
+2,828
New +$20.2K ﹤0.01% 13700
2026
Q1
– Sell
-8,844
Closed -$58.5K – 13132
2025
Q4
$58.5K Buy
+8,844
New +$70K ﹤0.01% 11950
2025
Q1
– Sell
-2,831
Closed -$41.6K – 14603
2024
Q4
$41.6K Buy
+2,831
New +$64.3K ﹤0.01% 12578
2023
Q2
– Sell
-17,512
Closed -$1.76M – 14442
2023
Q1
$1.76M Sell
17,512
-32,488
-65% -$3.26M ﹤0.01% 5629
2022
Q4
$5.05M Sell
50,000
-14
-0% -$1.39K ﹤0.01% 3841
2022
Q3
$4.92M Buy
50,014
+2
+0% +$196 ﹤0.01% 3906
2022
Q2
$4.9M Sell
50,012
-29
-0.1% -$2.84K ﹤0.01% 3825
2022
Q1
$4.89M Buy
50,041
+40
+0.1% +$3.89K ﹤0.01% 4218
2021
Q4
$4.88M Buy
50,001
+1
+0% +$98 ﹤0.01% 4333
2021
Q3
$4.85M Buy
+50,000
New +$4.84M ﹤0.01% 4359

Other funds holding COCH

Citadel Advisors's COCH Position: Q3 2026 in Review

Citadel Advisors opened a new position in Envoy Medical (COCH) in Q3 2026: 2,828 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #13700 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in COCH as recently as Q4 2025.

Citadel Advisors first reported a position in COCH in Q3 2021 and has held it in 10 quarters since. The position peaked at $5.05M in Q4 2022. 33 funds tracked by Wall St. Rank hold COCH as of Q3 2026.

  • Citadel Advisors held 2,828 shares of Envoy Medical worth $19.3K as of Q3 2026.
  • Envoy Medical was a new Citadel Advisors position in Q3 2026.
  • Envoy Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13700 holding.
  • Citadel Advisors first reported a position in Envoy Medical in Q3 2021 and has held it in 10 quarters since.
  • Citadel Advisors's Envoy Medical position peaked at $5.05M in Q4 2022.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.